Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gimatecan vs standard chemotherapy in second-line pancreatic cancer
CTR20201923Phase 2Terminated
- Sponsor
- China Oncology Focus
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gimatecan in pancreatic cancer (PC), sponsored by China Oncology Focus. Started Sep 2020; status: terminated.
02
Drugs
gimatecan
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on CTR20201923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201923.